First humans receive experimental drug in early safety trial
NCT ID NCT07219368
Summary
This is the first study testing the experimental drug MT-201 in humans. Researchers will give single and multiple doses to 72 healthy volunteers to check for side effects and see how the body processes the drug. The main goal is to determine if MT-201 is safe enough for further testing in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mirador Clinical Department, San Diego, California 92121
RECRUITINGSan Diego, California, 92121, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.